Brogan Financial Inc. Boosts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Brogan Financial Inc. boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 7.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 792 shares of the healthcare conglomerate’s stock after buying an additional 53 shares during the quarter. Brogan Financial Inc.’s holdings in UnitedHealth Group were worth $401,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BTG Pactual Asset Management US LLC grew its stake in UnitedHealth Group by 19.9% during the 4th quarter. BTG Pactual Asset Management US LLC now owns 3,673 shares of the healthcare conglomerate’s stock valued at $1,858,000 after acquiring an additional 609 shares in the last quarter. Altman Advisors Inc. increased its stake in UnitedHealth Group by 1.5% during the fourth quarter. Altman Advisors Inc. now owns 3,103 shares of the healthcare conglomerate’s stock worth $1,570,000 after acquiring an additional 47 shares during the last quarter. TCM Advisors LLC increased its holdings in UnitedHealth Group by 7.5% in the 4th quarter. TCM Advisors LLC now owns 1,433 shares of the healthcare conglomerate’s stock valued at $725,000 after purchasing an additional 100 shares during the last quarter. Sagespring Wealth Partners LLC acquired a new position in UnitedHealth Group during the fourth quarter worth $8,860,000. Finally, Distillate Capital Partners LLC raised its holdings in shares of UnitedHealth Group by 19.7% in the 4th quarter. Distillate Capital Partners LLC now owns 143,861 shares of the healthcare conglomerate’s stock valued at $72,774,000 after buying an additional 23,635 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. Piper Sandler cut their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Barclays reduced their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Truist Financial boosted their target price on UnitedHealth Group from $610.00 to $660.00 and gave the stock a “buy” rating in a research note on Friday. Finally, KeyCorp reiterated an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty-one investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and an average target price of $632.85.

UnitedHealth Group Price Performance

Shares of UNH opened at $599.10 on Friday. The firm has a fifty day moving average price of $512.87 and a 200 day moving average price of $542.03. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The stock has a market cap of $548.00 billion, a PE ratio of 38.65, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $5.83 earnings per share. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.40%. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.